F. Ueckeroth

发表

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

T. Buhl, J. Wolf, S. Perner, 2015, International journal of cancer.

Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.

M. Hellmich, R. Hein, M. Sos, 2016 .

the International Association for the Study of Lung Cancer Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015 .

Genetic Heterogeneity of MET-aberrant Non-Small Cell Lung Cancer and its Impact on the Outcome of Immunotherapy.

N. Reinmuth, J. Panse, J. Wolf, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

M. Hellmich, T. Zander, Y. Ko, 2014, Oncotarget.

Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non–Small Cell Lung Carcinoma (NSCLC)

Y. Ko, J. Wolf, R. Büttner, 2018, Clinical Cancer Research.

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer

T. Zander, M. Odenthal, M. Loeffler, 2015, Gut.

Clinical andPathologicalCharacteristicsofKEAP1- and NFE2L2-Mutated Non–Small Cell Lung Carcinoma (NSCLC)

er, Y. Ko, L. Heukamp, 2018 .

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

K‐ras Mutation Subtypes in NSCLC and Associated Co‐occuring Mutations in Other Oncogenic Pathways

M. Hellmich, Roman K. Thomas, Y. Ko, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Roman K. Thomas, T. Zander, D. Seidel, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

1300PDImpact of co-occurring genomic alterations on overall survival of BRAF V600E and non-V600E mutated NSCLC patients: Results of the Network Genomic Medicine

R. Riedel, J. Wolf, R. Büttner, 2017 .

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

T. Zander, M. Odenthal, Y. Ko, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.